Senior Vice President and Chief Commercial Officer
Richard Davies brings more than 20 years of diverse strategic and operational experience in the pharmaceutical and biopharmaceutical industries to his role as Hospira's chief commercial officer. Davies, who joined Hospira in February 2012, is responsible for developing and executing Hospira’s global commercial strategies and delivering profitable revenue growth across the company’s product portfolio.
Davies has a track record of success in a variety of commercial management positions and across a range of products and technologies. Before assuming his role as CCO at Hospira, Davies served as vice president and general manager, Japan, Asia Pacific and Latin America, for Amgen, where he was responsible for establishing Amgen’s business in the region as well as supporting its strategy development for emerging markets overall. During his eight years at Amgen, he led the company’s commercial organizations in Central/Eastern Europe and Australia, and also served as vice president of U.S. sales for the immunology franchise. Prior to joining Amgen, Mr. Davies spent 13 years at Eli Lilly and Company in increasing roles of commercial responsibility, including general country management.
Born and educated in the United Kingdom, Mr. Davies earned his bachelor's degree in applied chemistry from the University of Portsmouth and his master of business administration degree from the University of Warwick.